LONDON, April 15 (LPC) - A €185m (US$209.27m)leveraged loan financing backing Eurazeo’s buyout of Netherlands-based medical equipment provider DORC has closed and allocated on Europe’s secondary loan ...

Eurazeo has been a majority shareholder in DORC since 2019 Carl Zeiss Meditec is buying DORC from Eurazeo Eurazeo is a European investment group Eurazeo has entered into exclusive discussions to sell ...

Please provide your email address to receive an email when new articles are posted on . Carl Zeiss Meditec AG will acquire Dutch Ophthalmic Research Center in 2024. The transaction is valued at ...

JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...

OPTIMIZED RETINAL SURGICAL EXPERIENCE: Announcing updates to DORC instruments to expand surgeons' options, including new gauges added to the range of subretinal injection cannulae and a new Midfield ...

GE Capital International and Ares Management Ltd. have acted as Mandated Lead Arrangers for €110 million of unitranche, working capital and acquisition facilities for DORC Holding BV (“DORC”). The ...

Narrow-moat Carl Zeiss announced today that it has agreed to acquire Dutch Ophthalmic Research Center, or DORC, for roughly EUR 985 million. DORC is a supplier of ophthalmic instruments and equipment ...

ZEISS Medical Technology announced that the ILM staining dye ILM-Blue from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) ...

Montagu Private Equity LLP agreed to buy DORC Holding BV, a Dutch provider of instruments for eye surgery, from a group of investors including Rabobank Groep’s private-equity unit. The buyout firm ...

JENA, Germany and DUBLIN, Calif., Oct. 7, 2025 /PRNewswire/ -- ZEISS Medical Technology will showcase its latest enhancements in ophthalmic visualization and digital workflow innovation at the ...

"ZEISS continues to be at the forefront of optical and digital innovation, advancing our clinical workflows to be more efficient and empowering for doctors and surgeons around the world to deliver ...

The MarketWatch News Department was not involved in the creation of this content. Showcasing at AAO 2025: -- NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing ...